Lamotrigine - NDC Database (Page 14)
46708-419 Oct 07, 2024
Lamotrigine 300 mg Oral Tablet, Extended Release by Alembic Pharmaceuticals Limited
Lamotrigine 300 mg Oral Tablet, Extended Release by Alembic Pharmaceuticals Limited
49884-484 Dec 16, 2015
Lamotrigine 25 1/1 Oral Tablet, Orally Disintegrating by Par Pharmaceutical Companies, Inc.
Lamotrigine 25 1/1 Oral Tablet, Orally Disintegrating by Par Pharmaceutical Companies, Inc.
49884-485 Dec 16, 2015
Lamotrigine 50 1/1 Oral Tablet, Orally Disintegrating by Par Pharmaceutical Companies, Inc.
Lamotrigine 50 1/1 Oral Tablet, Orally Disintegrating by Par Pharmaceutical Companies, Inc.
49884-486 Dec 16, 2015
Lamotrigine 100 1/1 Oral Tablet, Orally Disintegrating by Par Pharmaceutical Companies, Inc.
Lamotrigine 100 1/1 Oral Tablet, Orally Disintegrating by Par Pharmaceutical Companies, Inc.
49884-487 Dec 16, 2015
Lamotrigine 200 1/1 Oral Tablet, Orally Disintegrating by Par Pharmaceutical Companies, Inc.
Lamotrigine 200 1/1 Oral Tablet, Orally Disintegrating by Par Pharmaceutical Companies, Inc.
49884-604 Jan 18, 2013
Lamotrigine 250 mg 24 Hr Extended Release Enteric Coated Tablet by Par Pharmaceutical Inc.
Lamotrigine 250 mg 24 Hr Extended Release Enteric Coated Tablet by Par Pharmaceutical Inc.
49884-605 Jan 18, 2013
Lamotrigine 300 mg 24 Hr Extended Release Enteric Coated Tablet by Par Pharmaceutical Inc.
Lamotrigine 300 mg 24 Hr Extended Release Enteric Coated Tablet by Par Pharmaceutical Inc.
49884-880 Nov 27, 2015
Lamotrigine 25 1/1 Oral Tablet, Orally Disintegrating by Par Pharmaceutical Companies, Inc.
Lamotrigine 25 1/1 Oral Tablet, Orally Disintegrating by Par Pharmaceutical Companies, Inc.
49884-881 Nov 27, 2015
Lamotrigine 50 1/1 Oral Tablet, Orally Disintegrating by Par Pharmaceutical Companies, Inc.
Lamotrigine 50 1/1 Oral Tablet, Orally Disintegrating by Par Pharmaceutical Companies, Inc.
49884-882 Nov 27, 2015
Lamotrigine 50 1/1 Oral Tablet, Orally Disintegrating by Par Pharmaceutical Companies, Inc.
Lamotrigine 50 1/1 Oral Tablet, Orally Disintegrating by Par Pharmaceutical Companies, Inc.
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.